Based on the iShares Healthcare Innovation UCITS ETF USD (Acc) stock forecast from 0 analysts, the average analyst target price for iShares Healthcare Innovation UCITS ETF USD (Acc) is not available over the next 12 months. iShares Healthcare Innovation UCITS ETF USD (Acc)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of iShares Healthcare Innovation UCITS ETF USD (Acc) is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, iShares Healthcare Innovation UCITS ETF USD (Acc)’s stock price was EUR 6.65. iShares Healthcare Innovation UCITS ETF USD (Acc)’s stock price has changed by -0.22% over the past week, -5.38% over the past month and -2.59% over the last year.
No recent analyst target price found for iShares Healthcare Innovation UCITS ETF USD (Acc)
No recent average analyst rating found for iShares Healthcare Innovation UCITS ETF USD (Acc)
Company Overview iShares Healthcare Innovation UCITS ETF USD (Acc)
Stock Target Advisor's fundamental analysis for iShares Healthcare Innovation UCITS ETF USD (Acc)'s stock is Bearish.
2B78:XETRA stock's dividend yield is 0.60%.
Our analysis grades 2B78:XETRA stock's dividend yield at F. This means that 2B78:XETRA stock's dividend yield is above 3% of the stocks in the Others sector in the XETRA exchange.
Based on this 2B78:XETRA may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 2B78:XETRA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 2B78:XETRA's stock to indicate if its overvalued.
The last closing price of 2B78:XETRA's stock was EUR 6.65.
The most recent market capitalization for 2B78:XETRA is EUR 1.14B.
Unfortunately we do not have enough analyst data on 2B78:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains iShares Healthcare Innovation UCITS ETF USD (Acc)'s stock.
Sorry, we do not have any data on the number of employees for iShares Healthcare Innovation UCITS ETF USD (Acc).
Sorry we do not have any infomation available on iShares Healthcare Innovation UCITS ETF USD (Acc)'s address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 2B78:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
